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We have synthesized porcine insulin labelled with tritium at
position B-30 using enzyme-catalysed formation of a peptide
bond. The resulting insulin derivative has the label in the ex-
pected position and is biologically active. We have tested our
procedure to prepare batches up to 50 /tCi of tritiated
insulin at a specific radioactivity of up to 1.14 Ci/mmol.
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Introduction
Insulin plays an important role in the control of metabolism and
is crucial to the treatment of certain types of diabetes mellitus.
Such functions of insulin are influenced by processes that regulate
the amount of biologically-active insulin in the circulation. Label-
ling of the insulin molecule with tritium has proved useful for
studying these processes (Halban et al., 1976; Berger et al., 1978;
Morishima et al., 1985; Davies et al., 1986; Muir et al., 1986).
Labelling with tritium causes a minimal alteration to the hormone.
Tritiated tracers labelled either at phenylalanine-Bl (Halban and
Offord, 1975) or at glycine-Al (Davies and Offord, 1985) have
been synthesized and shown to behave authentically (Halban et
al., 1976; Morishima et al., 1985; J.G.Davies, unpublished
work). The labelled insulins mentioned above were produced
semisynthetically, using chemical means to bring about the essen-
tial steps of removal of an amino acid and its replacement by
one that is tritiated. Chemical methods (which require the tem-
porary protection of certain of insulin's functional groups) are
readily applicable to alterations at the amino terminus of a pep-
tide chain but are much more complicated to apply to substitu-
tion at the C-terminus. However, a carboxy-terminal labelled
insulin is desirable; for example, in their experiments on the
degradation of insulin, Muir et al. (1986) were unable to follow
the fate of the carboxy-terminal portion of insulin once it had
been cleaved from the labelled amino-terminal region.
The discoveries that proteases could be used not only to remove
a part of a protein but also to catalyse its replacement in high
yield by synthesis of peptide bonds, and that such syntheses are
readily applicable to carboxy-terminal modifications, gave rise
to the possibility of labelling insulin at position B-30 [see for ex-
ample Rose et al (1983) and references cited therein]. Temporary
protection of functional groups of the protein is generally not
required in such syntheses.
The purpose of this study was to synthesize and characterize
insulin labelled with tritium at postion B-30 (Scheme 1). We
found that satisfactory conditions for enzyme-catalyzed semisyn-
thesis of small quantities of radioactive material were much more
difficult to establish than for semisynthesis of non-radioactive
derivatives, irrespective of scale. This difficulty with enzyme-
Des-AlaB30-msulin + L-{3H]alanine methyl ester
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(L-[3-3H]AlaB3O)insulin
catalysed semisynthesis recalls that encountered earlier in effec-
ting chemical ones at high specific activity (Davies, 1981).
However, we describe below the successful use of the enzyme
Achromobacter lyticus protease (Morihara et al., 1980) to syn-
thesize a peptide bond between tritiated alanine methyl ester and
des-Ala -insulin. The use of odier enzymes for this synthesis
is also discussed.
Materials and methods
All reagents and solvents, unless otherwise specified, were ob-
tained from commercial sources, were of analytical grade or bet-
ter and were used without further purification.
Monocomponent porcine insulin was purchased from Novo
Industri, Copenhagen, Denmark. L-[3-3H]alanine and [U-I4C]-
glucose were obtained from New England Nuclear, Dreieich,
FRG. Dimethylformamide was obtained from Merck and was
redistilled before use, as described by Davies and Offord (1985).
Carboxypeptidase A was from Sigma, St Louis, MO, USA.
HPLC was performed on either of two systems, which have
previously been described: (i) a Waters system (Rose et al.,
1984), which has been modified by replacement of the manual
injector with an automatic one (Wisp model 710B, Waters). On
this system, solvent A was 1 g trifluoroacetic acid (h.p.l.c. grade,
Pierce) dissolved in 1 1 HPLC-grade water (Milli-Q system),
and solvent B was acetonitrile (LiChroSolv., Merck); (ii) a
Beckman 344 gradient system (Davies and Offord, 1985). On
diis system solvent A was 100 ml 3M (NH4)2SO4 adjusted to
pH 2.7 with concentrated sulphuric acid and then made up to
1 1 with HPLC-grade water. Solvent B was 100 ml 3M
(NH4)2SO4 adjusted to pH 2.7 with concentrated sulphuric acid,
mixed with 350 ml acetonitrile (LiChroSolv., Merck) and then
made up to 1 1 with HPLC-grade water. Because of the
phenomenon of electrocontraction, it is important to mix
thoroughly before the addition of the last few millilitres of water.
The column was a 250 X 4.6 mm RP18 Spheri-5 from Brownlee
Labs. USA.
Determination of radioactivity in solution was carried out in
Biofluor or Aquasol scintillation cocktails (New England Nuclear,
Boston, MA, USA) with a Beckman LS6800 liquid scintillation
counter. Radioactivity on paper electropherograms was deter-
mined by a Berthold windowless Linear Analyser.
Purification of L-[3-3H]alanine
The radioactive amino acid (3.5 mCi, 41 nmol at 85 Ci/mmol),
diluted to a nominal 2 Ci/mmol by the addition of 1.7 /tmol L-
alanine and lyophilized, was purified from non-radioactive, u.v.-
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absorbing (214 nm) material by HPLC (Waters system). The
sample was dissolved in 210/il 1.2 mMHClandof this, 200/d
were injected onto a reversed-phase column (220 X 4.6 mm with
a 30-mm guard column, Spheri-5 RP18, Brownlee Labs.)
equilibrated and eluted isocratically at 1 ml/min with solvent A.
Effluent was pooled in the period between 3 and 5 min after the
injection of the sample which corresponds to the elution posi-
tion of alanine as determined with a standard. After washing the
column with 10% solvent B and re-equilibrating with solvent A,
a second run was made with 200 /d tube washings, pooling the
column effluent as before. Recovery of alanine, on the basis of
radioactivity, was 91%.
Synthesis of L-[3-3H\alanine-methyl ester
After lyophilization, the radioactive amino acid from the previous
step was esterified with 0.5 ml 5.3 M HC1 in dry methanol at
room temperature overnight. T.l.c. (Polygram SU N-HR silica
plates, Macherey-Nagel and Co., Duren, FRG) in butan-1-ol/ace-
tic acid/water/pyridine (30:6:24:20 by vol.) showed more than
99% conversion to ester as judged by radioactivity (Berthold
Linear Analyser). Reagent and solvent were evaporated under
a stream of nitrogen. Determination of radioactivity in small
volumes of volatile solvents is difficult, and thus the recovery
was not estimated at this stage.
Enzyme-assisted coupling
Des-AlaB30-insulin was prepared essentially according to
Morihara et aL (1980). In a mixture of 0.5 M solutions of sodium
acetate and of acetic acid, both in butane-1,4-diol/water 9:1 (v/v),
a 10 mM solution of des-AlaB30-insulin was prepared, which
registered pH 7.0 at the uncorrected glass electrode. To the dry
radioactive amino acid methyl ester was added 49 /U of the des-
AlaB30-insulin solution, followed by 1.75 /d (acceptable limits,
± 0 . 1 /tl) of a solution of A. tyticus protease (Lysyl endopep-
tidase, Wako Pure Chemical Co.), 50 /tg/ml in water. After in-
cubation for 2 h at 22 °C the reaction mixture was quenched with
50 /tl acetic acid, followed by 100 /d water.
Isolation of [L-^
The quenched coupling mixture was chromatographed in three
portions on the Waters system. The column, a C18 Radialpak
/t-Bondapak cartridge in a Z-module, was equilibrated and then
eluted with 25% solvent B at 1 ml/min. After 5 min, a linear
gradient of +0.2% solvent B/min was applied for a further
50 min. Under these conditions, des-Ala -insulin and porcine
insulin B30-methyl ester, made as previously described (Rose
et al., 1983), elute at retention times of 39 and 42 min respec-
tively. The solvent fronts were pooled for recovery of the radioac-
tive alanine methyl ester. The radioactive protein peaks (insulin
methyl ester) were pooled, and the solvent was removed in a
vacuum centrifuge (Speed-Vac, Savant Instruments, Hicksville,
USA).
Deprotection of {L-[3-3H]AlaB30-OMe}insulin
The (L-[3-3H]AlaB30-OMe)insulin was redissolved in 50 /d di-
methylformamide/water 1:1 (v/v) and cooled to 0°C on ice. This
corresponds to 4.4 mg/ml estimated on the basis of the radioac-
tivity and assuming a nominal 2 Ci/mmol. Fifty microlitres of
1 M NaOH, which had been previously cooled on ice, were ad-
ded and after 20 s on ice, 25 /tl glacial acetic acid were ad-
ded. The reaction mixture was then applied directly to reversed-
phase HPLC (Beckman system). The column was a Brownlee
RP18 Spheri-5, equilibrated and eluted with a percentage of sol-
vent B such drat insulin elutes with a retention time of —10 min
at a flow of 1 ml/min (actual conditions: 69% B, retention time
of porcine insulin = 10.2 min). Under equivalent conditions,
insulin had been shown to separate from [AlaB30-OMe]insulin,
which eluted with a retention time 1.6 times greater than that
of insulin. The pooled insulin peak was then applied to a Sep-
pak C18 cartridge (Waters) previously equilibrated in acetoni-
trile/water/trifluoroacetic acid 20:80:0.1 (by vol.) and washed
with 20 ml of the same solvent mixture. The insulin was eluted
from the cartridge with 4 ml acetonitrile/water/trifluoroacetic acid
40:60:0.1 (by vol). The acetonitrile was removed by evapora-
tion with a stream of filtered compressed air and the resulting
solution lyophilized. The sample was resuspended in 0.5 ml
0.14% (w/v) CH3COONa/0.7% (w/v) NaCl and dissolved by
the careful addition of powdered solid Tris base of pH 8.5. The
solution was then saturated with the bacteriostat p-methylbenzoic
acid and sterilized by filtration through a Sartorius 0.2 /tm
cellulose acetate filter (SM 11107). Samples were removed for
determination of the radioactivity and other types of characteriza-
tion. The solution was stored at 4°C.
Characterization
Reversed-phase HPLC. (L-^HlAla^jinsulin (0.05 /tCi) was
mixed with 10 /tg of unlabelled porcine insulin and injected
onto reversed-phase HPLC (Beckman system with a Brownlee
RP18 Spheri-5 column). The insulin was eluted isocratically at
1 ml/min with 71% solvent B for 15 min and a linear gradient
of +14.5% solvent B/min was then applied to 100% solvent B.
The effluent was collected in 0.5-min fractions and 0.2-ml ali-
quots taken for determination of radioactivity.
Separation of the oxidized insulin chains. {L-^HlAla^insulin
(0.05 /tCi) was mixed with 100 /tg unlabelled porcine insulin and
lyophilized. The sample was redissolved in 9 /tl formic acid and
1 /d hydrogen peroxide (30% in water) was added to oxidize the
disulphide bonds. After 8 min at room temperature the reaction
was quenched by the addition of 0.5 /tl 0.2 M NaHCO3. The
resulting solution was injected onto reversed-phase HPLC
(Beckman system, Brownlee RP18 Sphen-5 column) equilibrated
with 28.6% solvent B (10% acetonitrile) and a gradient of
+4.76% solvent B/min (+1 % acetonitrile/min) applied to 100%
solvent B (35% acetonitrile), flow rate 1 ml/min. Fractions were
collected every 0.2 min and the radioactivity in each determined.
Cleavage of [L-[3-3H]AlaB3O]insulin with Armillaria mellea pro-
tease. This protease [isolated by the method of Gregory and
Walton (1976) from mushrooms growing in western Switzerland
and neighbouring regions of France] cleaves specifically at the
peptide bond on the amino-terminal side of lysine residues. As
the only lysine residue in insulin is at position B-29, this enzyme
releases the peptide Lys —Ala from porcine insulin.
{L-P^HlAla^insulin (0.05 /tCi) was added to 50 /tg un-
labelled porcine insulin already dissolved in 5 /tl 2.5% (w/v)
NH4HCO3. To this solution were added 8 /d water and after
warming to 37 °C, 1 /tl A. mellea protease in water (the protease
is active in very dilute solutions and so the exact enzyme con-
centration was unknown; trial experiments had shown this volume
to be required). After 4 h at 37°C the sample was loaded onto
Whatman 3MM paper and dried under high vacuum. The pep-
tide Lys-Ala was separated from the cleaved protein by paper
electrophoresis at pH 6.5, the radioactivity detected with a Ber-
thold Linear Analyser and the peptide arid protein detected by
staining with ninhydrin-cadmium (Offord, 1969). Mobility (m)
was determined with respect to aspartic acid.
Specific radioactivity. The specific radioactivity of the
{L-[3-3H]AlaB3O)insulin was determined by comparison of
the area under the insulin peak obtained by reversed-phase
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Figure 1. Reversed-phase HPLC of (A) ( L - ^ H J A l a ^ i n s u l i n and (B) (L-[3-3H]AlaB3O)insulin after oxidation in perfornuc acid The elution position of
standards detected by absorption at 214 nm is indicated The minor peak eluting after the main B-chain peak in B is also present in the profile of absorbance
at 214 nm This peak was taken to represent oxidized B-chain which had been further modified by the performic acid, since its size increases with time of
oxidation as that of the major B-chain peak decreases (data not shown). Both analyses were earned out on the Beckman system. The unoxidized insulin (A)
was eluted under isocratjc conditions at 71 % solvent B followed by a gradient to 100% solvent B. The oxidized insulin was eluted with a gradient of
+4.76% solvent B/min ( + 1 % acetonitrile/min) from 28 6% solvent B (10% acetonitnle) to 100% solvent B (35% acetonitnle).
HPLC of this material with that of a standard porcine insulin
solution. The quantity of insulin present in 10 /tl of the
[L-^HJAla^insulin solution was calculated from the concen-
tration of radioactivity assuming a specific radioactivity of
2 Ci/mmol. A standard solution of porcine insulin was adjusted
to this concentration on the basis of its absorbance at 280 nm
and five injections of 10 /d each made on the Beckman HPLC,
Brownlee RP18 Speri-5 column, gradient 57.1-100% B
(20—35% acetonitnle) over 15 min at 1 ml/min. The area under
the insulin peak at 214 nm was calculated in each case and the
mean value calculated (5). Ten microlitres of the
{L-[3-3H]AlaB3O]insulin solution were then injected and the area
under the insulin peak also calculated (A). The true sp. act. was
then calculated as 2 x SI A Ci/mmol.
Biological characterization. The biological activity of the
(L-[3- H]AlaB30]insulin was tested as the stimulation of incor-
poration of [U- C]glucose into lipid in isolated rat fat cells by
the method of Moody et al. (1974).
Cleavage with carboxypeptidase A. The tritiated alanine was
cleaved from the radioactive insulin molecule with carboxypep-
tidase A by the method of Schmht and Gattner (1978), with minor
modifications. Carboxypeptidase A was treated as described by
Offord (1980). Fifty microlitres (2.73 /xCi or 2.4 nmol at
1.14 Ci/mmol) [L-P^HJAla^jinsulin was lyophilized and
redissolved in 10 /J 0.1 M ammonium bicarbonate. Carboxy-
peptidase A (10 mil) was added in 1 /J 2 M ammonium bicar-
bonate and the reaction left at room temperature for 16 h. The
products of this reaction were passed through a Sep-pak cartridge
previously equilibrated in water/trifluoroacetic acid 100:0.1 (v/v).
The cartridge was then washed with a further 20 ml of this sol-
vent. Aliquots were removed for the determination of radio-
activity. The eluant fractions, containing cleaved tritiated alanine
which does not bind to the Sep-pak under these conditions, were
pooled and lyophilized. Two millilitres of water/acetonitrile/tri-
fluoroacetic acid 60:40:0.1 (by vol.) were then passed through
the Sep-pak to remove the des-Ala-insulin and any uncleaved in-
sulin, and aliquots of this eluant removed for determination of
the radioactivity. The lyophilized material was resuspended in
250 /d of a standard mixture containing 10 nmol/ml of each of
18 amino acids. Fifty microlitres were applied to an amino acid
analyser and the quantity of alanine determined relative to the
standard mixture on its own, using methionine (which is not pre-
sent in porcine insulin) as an internal standard. Three aliquots
of 50 fi\ were removed for determination of the radioactivity in
the solution applied to the amino acid analyser. This value,
together with the quantity of alanine cleaved from the tritiated
insulin by carboxypeptidase A, was then used to calculate the
sp. act. of the tritiated alanine in the radioactive insulin
preparation.
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Figure 2. Paper electrophoresis of the result of cleavage of
(L-[3-3H]Ala^3O)insulin with Armillaria mellea protease Radioactivity was
detected by a Berthold Linear Analyser. The pepbde Lys-Ala, which is
released from the carboxy-terminus of the insulin B-chain by this enzyme,
was detected by staining with ninhydnn-cadmium (predicted m •= 0 72,
observed m = 0.7). (1) (L-{3-3H]AlaB3O)insulin after treatment with enzyme,
(2) (L-[3-3H]AlaB36]insulin
Results and discussion
Enzyme-assisted coupling
Very high coupling yields, based on protein substrate, may be
obtained under conditions of thermodynamic control when us-
ing a large excess of a nucleophile [see e.g. Rose et al. (1983)].
In die case of an expensive nucleophile, and in particular a
radioactive one, it is neither possible nor desirable to work with
large volumes of concentrated reagent. For this reason, we per-
formed preliminary experiments in which we varied the concen-
tration of both des-AlaB30-insulw and alanine methyl ester
(unlabelled or < < 2 Ci/mmol). The results (data not shown)
indicated diat to obtain maximum yield with respect to alanine
methyl ester, the des-AlaB30-insulin concentration should be as
high as possible in the range tried (up to 10 mM, close to the
limit of solubility). Also the alanine methyl ester concentration
should be as low as possible in the range tried (down to 30 mM).
With the amino acid ester at 30 mM, equilibrium yields of
coupled product were - 2 0 % based on des-Ala-insulin
(~7% based on amino acid ester). Since both the preparation
of truncated polypeptide precursors and the coupling reaction
itself are very simple to carry out compared to what is necessary
to prepare (L[3H]GlyA1)insulin (Davies and Offord, 1985) and
(L[iH]PheB1)insulin (Halban and Offord, 1975), a rather low
radiochemical yield is not a great problem: the label can in prin-
ciple be recycled.
Deprotection and purification
Insulin is know to withstand the relatively harsh conditions used
for the removal of methylsulphonylethyloxycarbonyl (Msc)
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Figure 3. Stimulation of incorporation of [U-l4C]glucose into lipid in
isolated rat fat cells Unlabelled insulin ( O ~ O ) , (L-pJHJAlaBMlinsulin
( • D) Results are the means of three of four observations at each
concentration of insulin or derivative, with the standard deviation
groups (Geiger et al., 1975; Davies and Offord, 1985). We
therefore chose these conditions for the saponification of the
mediyl ester group at position B-30. Reversed-phase HPLC
(Beckman system) showed that 75% or more of the ester was
hydrolyzed. In addition only 2% of the radioactivity eluted at
the column breakthrough indicating that loss of tritium from the
amino acid residue is not a major problem. The yield after de-
protection was 2.2% based on recovery of radioactivity from the
3.5 mCi used at the outset. At 1.14 Ci/mmol (see Characteriza-
tion below) this gives a yield of 13% of the protein present in
the coupling reaction. The final yield was 1.5% based on radio-
activity and 9.4% on the basis of protein.
Characterization
(L-[3-3H]AlaB3Oj insulin behaves as unlabelled insulin on isocratic
elution from reversed-phase h.p.l.c. (Figure 1A). The tritiated
insulin was cleaved chemically and enzymatically to investigate
the position of the label on die molecule. Thus, after oxidation
in performic acid, 94.7% of the radioactivity was associated with
the B-chain on reversed-phase HPLC (Figure IB). The chemical
nature of the remaining radioactivity was not determined, but
1.7% eluted at the column breakthrough, 3.0% on the gradient
before the oxidized B-chain (probably representing partially ox-
idized insulin) and a further 0.6% after the B-chain. Following
cleavage of me tritiated insulin with A.mellea protease, paper
electrophoresis showed that 92% of die radioactivity was
associated with the peptide Lys-Ala, die carboxy-terminal dipep-
tide of the B-chain. The remaining radioactivity stays at the
electrophoretic origin as does all die label in a control where en-
zyme was not added to die insulin (Figure 2).
The concentration of die tritiated insulin was determined by
reversed-phase HPLC. The sp. act. dius calculated was 1.14
Ci/mmol rather than the nominal 2 Ci/mmol to which die tritiated
alanine had been diluted at the outset. We dierefore determined
die specific radioactivity of die alanine which was present at posi-
tion B-30 in die tritiated insulin. Carboxypeptidase A cleavage
of die alanine and subsequent passage tiirough a Sep-pak car-
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tridge showed that 96% of the radioactivity was removed from
the insulin by this treatment. Subsequent amino acid analysis
showed that the specific radioactivity of the tritiated alanine was
1.17 Ci/mmol. This value is essentially the same as that of the
tritiated insulin indicating that there is no major contamination
with des-Ala^-insulin. The discrepancy from the nominal value
of 2 Ci/mmol could have arisen from the fact that the tritiated
alanine as purchased contained volatile radioactive contaminants
or exchangeable tritium on some atom other than C-3. In addi-
tion the possibility of an unfavourable secondary isotope effect
operating during the coupling step cannot be ruled out. The
specific biological activity of the tritiated insulin resembles that
of a standard porcine insulin (Figure 3).
Alternative enzymes
Whilst an acceptable yield of product may be obtained with A.
lyticus protease, other enzymes which are known to catalyse such
reactions have proved to be less useful. Carboxypeptidase Y, used
under fully aqueous conditions with insulin B30-amide and alanine
amide as substrates, gave side products (not characterized) which
were difficult to separate from the desired product and yields
were low. Bovine trypsin (known to be less robust than the por-
cine form) appears to be very sensitive to the coupling reaction
conditions, possibly due to the production of free radicals by the
interaction of the radiation with the solvents: yields are high with
unlabelled amino acid esters but become unacceptably low when
the alanine is tritiated. However, porcine trypsin is much more
resistant to the coupling conditions and yields in the presence
of this enzyme were almost as high as with A. lyticus protease.
Conclusion
We have prepared tritiated insulin specifically labelled at posi-
tion B-30. The specific activity of this insulin tracer is sufficient
to carry out studies in vitro and in vivo on insulin processing.
Measurable quantities of radioactivity are present at high physio-
logical concentrations with this sp. act.: 1 nM insulin would give
~2000 d.p.m./ml. Higher specific activities are sometimes
preferable (Davies and Offord, 1985), as they allow work at lower
insulin concentrations, and are theoretically possible since the
original labelled amino acid can be purchased at up to 85
Ci/mmol. The cost may become the deciding factor as scaling
down the synthesis to give a coupling volume of less than 10 /tl
is not recommended.
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